Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-546-8 | CAS number: 12009-21-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Deviations:
- no
- Principles of method if other than guideline:
- The detailed method followed in this study is described in XCellR8 SOP L0057 ‘Skin Sensitisation Key Event 2 (KeratinoSensTM) following guideline OECD TG442D’, and is based on the KeratinoSensTM assay, adapted to fully animal product-free conditions by XCellR8 and validated in-house (studies 14XC004, 15XC001, 16XCO04) using the 10 proficiency chemicals and 11 reference chemicals described in TG 442D. Luciferase measurements and MTT viability testing were performed at the end of the appropriate exposure period (48h).
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- Barium zirconium trioxide
- EC Number:
- 234-546-8
- EC Name:
- Barium zirconium trioxide
- Cas Number:
- 12009-21-1
- Molecular formula:
- BaO3Zr
- IUPAC Name:
- barium(2+);oxygen(2-);zirconium(4+)
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- Supplier batch/lot number 17/1791
CAS number 12009-21-1
Purity 99.17 %
Expiry Date 27SEP2020
Physical state: Powder (white)
Concentrations tested (µg/ml) 0.488, 0.977, 1.953, 3.906, 7.813, 15.625, 31.250, 62.500, 125.00, 250.000, 500.000, 1000.000
In vitro test system
- Details on the study design:
- Method of administration of test item:
Per plate, a single application of 12 concentrations of the test item was applied in cell culture medium (dilution factor of 2) with a final concentration of DMSO of 1%. The top concentration was previously determined by solubility testing.
Method of administration of reference items:
Per plate, a single application of 5 concentrations of the positive control was applied in cell culture medium (dilution factor of 2) with a final concentration of DMSO of 1% and a single application of culture medium with 1% DMSO was applied as the negative control (6 wells per plate). One well per plate was left empty (no cells).
Exposure times of test items and reference items:
Cells were incubated with the test or reference item for 48 ± 2h prior to endpoint measurements
Number of repetitions
Three repetitions (runs) were performed. Each repetition consisted of 3 x 96-well plates for luminescence (n=9 overall) and 2 x 96-well plates for MTT (n=6 overall). The validity of each repetition was assessed following acceptance criteria
Results and discussion
- Positive control results:
- Test results are acceptable if:
The positive control (cinnamic aldehyde) produces positive results, i.e. the luciferase gene induction produced by this control is above the threshold of 1.5 in at least one of the tested concentrations and this induction is statistically significant compared to the solvent (negative) control (p<0.05).
The lMAX and the EC1.5 for cinnamic aldehyde is calculated and meet either or both of the following targets:
o Average induction in the three replicates for cinnamic aldehyde at 32 µM is within the XCellR8 historical range (currently 1.6 and 3)
o EC1.5 value for cinnamic aldehyde is within the XCellR8 historical range (currently 6 µM and 39 µM).
Note: At least one of these criteria must be met, otherwise the run is discarded unless there is sufficient reason not to do this as determined by the Study Director.
If only one criterion is met, it is recommended to check the dose-response curve of cinnamic aldehyde in order to decide on acceptability.
CV% of blank values < 20%
Criteria Result PASS or FAIL
Positive Control (PC) (Cinnamic aldehyde) induction >1.5-fold in at least one concentration Yes (4/5) PASS
Average induction of PC at 32µM is [1.6-3.0] Yes (2.973) PASS
EC1.5 value is [6-39µM] Yes (9.950µM) PASS
CV% of blank values < 20% Yes (13.4393) PASS
In vitro / in chemico
Results
- Key result
- Run / experiment:
- other: Mean of three runs
- Parameter:
- other: Two parameters: EC1.5 and the IMAX value
- Remarks:
- The EC1.5 value is the Effective Concentration (EC) of test item that yielded an induction of luciferase activity greater than 1.5-fold over untreated controls. The IMAX value is the maximum induction observed within the concentration range tested
- Vehicle controls validity:
- valid
- Remarks:
- 1% DMSO in cell culture medium
- Negative controls validity:
- valid
- Remarks:
- 1% DMSO
- Positive controls validity:
- valid
- Remarks:
- 1 Cinnamic Aldehyde in DMSO
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- The test item did not induce statistically significant luciferase induction >1.5 in any of the 3 repetitions. The IMAX value is the maximum induction observed within the concentration range tested. Although the KeratinoSensTM test is not validated to predict potency, the IMAX value can provide a useful tool for preliminary comparison of sensitisation potential between test items. The maximum induction was observed at a test concentration of 7.813 µM, which showed an IMAX value of 1.077 in repetition 1; the IMAX in repetition 2 was 0.755 at a concentration of 500.000 µM and in repetition 3 the IMAX was 1.019 at 62.500 µM in repetition 3. For reference, during test validation, sensitising proficiency chemicals produced IMAX values of up to 36-fold over untreated controls
Any other information on results incl. tables
Determination criteria for the skin sensitisation potential ofthe test item |
|||
|
REP1 |
REP2 |
REP3 |
Does at least one concentration ofTest Iteminduce luciferase activity>1.5-fold: |
No |
No |
No |
Does the first concentration inducing luciferase activity above 1.5, have a viability above 70%: |
N/A |
N/A |
N/A |
Is p value < 0.05 for at least one concentration that yielded>1.5-fold induction with viability above 70% |
N/A |
N/A |
N/A |
Does EC1.5value occur at a concentration <1000µM (or <200µg/ml) |
N/A |
N/A |
N/A |
Does the test item induce the luciferase in a dose-dependent manner |
N/A |
N/A |
N/A |
Classification |
Negative |
Negative |
Negative |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The human skin sensitisation potential of Barium Zirconate was assessed using the validated in vitro method: the KeratinoSensTM test to determine keratinocyte activation. The method was adapted to animal product-free conditions by XCellR8 and reference chemicals described in the guideline and in the performance standards were used to confirm the reliability, accuracy, sensitivity and specificity values.
In this study, Barium Zirconate was classified as Negative using the KeratinoSens prediction model.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.